These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 10784232)
1. Significance of GAD positivity in elderly patients with diabetes. Meneilly GS; Tildesley H; Elliott T; Palmer JP; Juneja R Diabet Med; 2000 Mar; 17(3):247-8. PubMed ID: 10784232 [No Abstract] [Full Text] [Related]
2. GAD antibodies in elderly men in different categories of glucose tolerance. Ylihärsilä H; Tuomilehto J; Mackay IR; Zimmet P; Tuomilehto-Wolf E; Rowley MJ; Nissinen A Diabetes Care; 1999 Jun; 22(6):996-7. PubMed ID: 10372254 [No Abstract] [Full Text] [Related]
3. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients. Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671 [TBL] [Abstract][Full Text] [Related]
4. Glutamic acid decarboxylase antibodies and diabetes complications. Assay reliability and validity. Lernmark A Diabetes Care; 1995 Feb; 18(2):269-71. PubMed ID: 7729309 [No Abstract] [Full Text] [Related]
5. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies]. Yang L; Zhou ZG; Huang G; Yan X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967 [TBL] [Abstract][Full Text] [Related]
6. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. Richter W; Mertens T; Schoel B; Muir P; Ritzkowsky A; Scherbaum WA; Boehm BO J Exp Med; 1994 Aug; 180(2):721-6. PubMed ID: 7913951 [TBL] [Abstract][Full Text] [Related]
7. Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities Study. Vigo A; Duncan BB; Schmidt MI; Couper D; Heiss G; Pankow JS; Ballantyne CM Braz J Med Biol Res; 2007 Jul; 40(7):933-41. PubMed ID: 17653446 [TBL] [Abstract][Full Text] [Related]
8. Development and progression of diabetic retinopathy in patients with Type 1 diabetes who are positive for GAD autoantibody. Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Noma H; Amano S; Araie M; Iwamoto Y; Hori S Diabet Med; 2004 Jun; 21(6):559-62. PubMed ID: 15154939 [TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus. Humphrey AR; McCarty DJ; Mackay IR; Rowley MJ; Dwyer T; Zimmet P Diabet Med; 1998 Feb; 15(2):113-9. PubMed ID: 9507910 [TBL] [Abstract][Full Text] [Related]
10. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon. Hawa MI; Picardi A; Costanza F; D'Avola D; Beretta Anguissola G; Guglielmi C; Mottini G; Fezeu L; Mbanya JC; Leslie RD; Pozzilli P Clin Immunol; 2006; 118(2-3):229-32. PubMed ID: 16298164 [TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender. Zimmet PZ; Elliott RB; Mackay IR; Tuomi T; Rowley MJ; Pilcher CC; Knowles WJ Diabet Med; 1994 Nov; 11(9):866-71. PubMed ID: 7705024 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Tuomilehto J; Zimmet P; Mackay IR; Koskela P; Vidgren G; Toivanen L; Tuomilehto-Wolf E; Kohtamäki K; Stengård J; Rowley MJ Lancet; 1994 Jun; 343(8910):1383-5. PubMed ID: 7910881 [TBL] [Abstract][Full Text] [Related]
13. Stiff, twitchy or wobbly: are GAD antibodies pathogenic? Vincent A Brain; 2008 Oct; 131(Pt 10):2536-7. PubMed ID: 18799517 [No Abstract] [Full Text] [Related]
14. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies. Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase. Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927 [TBL] [Abstract][Full Text] [Related]
16. Role of beta-cell autoantibodies as a predictor marker in diabetic patients and their relationship to glycemic control. Ali NA; Swelam E; AI Banna EA; Showkry A Egypt J Immunol; 2012; 19(1):39-49. PubMed ID: 23888550 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to GAD in diabetic patients with chronic hepatitis C. Ando H; Nagai Y; Yokoyama M; Takamura T; Kobayashi K Diabet Med; 1998 Sep; 15(9):797. PubMed ID: 9737812 [No Abstract] [Full Text] [Related]
18. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients. Roll U; Christie MR; Standl E; Ziegler AG Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311 [TBL] [Abstract][Full Text] [Related]
19. Seroconversion of GAD antibody in unclassified diabetes with long duration of disease. Shigihara T; Shimada A; Saisho Y; Kawai T; Maruyama H; Saruta T Diabetes Care; 2004 Jul; 27(7):1836-7. PubMed ID: 15220276 [No Abstract] [Full Text] [Related]
20. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults]. Huang YY; Huang P; Lou HL Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]